Vienna, Austria

Ernst Wenzel

This inventor holds 1 USPTO granted patent. Top assignee: Pentapharm Ag. Active years: 1993.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ernst Wenzel. Retrieved from https://idiyas.com/inventor/ernst-wenzel

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 2.0

ph-index = 1

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 1993

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Ernst Wenzel

Introduction

Ernst Wenzel is a notable inventor based in Wien, Austria. He has made significant contributions to the field of medical technology, particularly in the area of blood sample treatment. His work focuses on improving the processes involved in blood analysis and treatment.

Latest Patents

Wenzel holds a patent for "Inhibitors for the anticoagulant pretreatment of blood samples." This invention includes Meizothrombin- and thrombin-inhibiting inhibitors that do not bind bivalent cations. These inhibitors are essential for the anticoagulant pretreatment of blood samples, which are used to determine the functions and changes of state of blood cells and corpuscles. The patent also addresses the treatment of devices and receptacles used for taking and receiving blood samples.

Career Highlights

Ernst Wenzel is associated with Pentapharm AG, a company that specializes in medical and pharmaceutical innovations. His work at Pentapharm AG has allowed him to focus on developing solutions that enhance the accuracy and reliability of blood sample analysis.

Collaborations

Wenzel collaborates with Kurt F. Stocker, who is also involved in the field of medical technology. Their partnership has contributed to advancements in the development of anticoagulant treatments.

Conclusion

Ernst Wenzel's innovative work in the field of blood sample treatment has led to significant advancements in medical technology. His patent for anticoagulant inhibitors showcases his commitment to improving healthcare solutions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…